During the past decade, Hopital Robert Debre; Hematologie Clinique conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Robert Debre; Hematologie Clinique" #1 sponsor was "French Innovative Leukemia Organisation" with 7 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "University Hospital, Lille" with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Intergroupe Francophone du Myelome" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Robert Debre; Hematologie Clinique" #1 collaborator was "Acute Leukemia French Association" with 2 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "French Intergroup of Myeloproliferative syndromes" with 1 trials as a collaborator and "Group for Research in Adult Acute Lymphoblastic Leukemia" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Robert Debre; Hematologie Clinique" are "Multiple Myeloma" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloblastic Leukemia" (1 trials) and "Blood Stem Cell Transplant Failure" (1 trials). Many other conditions were trialed in "Hopital Robert Debre; Hematologie Clinique" in a lesser frequency.

Most popular intervention types in "Hopital Robert Debre; Hematologie Clinique" are "Drug" (11 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Fludarabine" (3 trials), "Bendamustine" (2 trials), "Obinutuzumab" (2 trials) and "Blinatumomab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Robert Debre; Hematologie Clinique" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Robert Debre; Hematologie Clinique". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hopital Robert Debre; Hematologie Clinique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Robert Debre; Hematologie Clinique, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".